Insider trade

CEO sold ~$66K of EW shares in the open market

Traded May 12, 2026 · Filed May 12, 2026

~$66K
Reported value · 845 sh @ $78.40: 48K
Holds after · shares reported: +9.4%
stock since the trade · S&P 500 +5.0%, $79.73 → $87.23 on Oct 5

Why it stands out

The boss of Edwards Lifesciences sold $66K of Edwards Lifesciences shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 12, 2026
Reporting period: Not applicable
Filed with the SEC: May 12, 2026

CEOIndirect holding$25K–$100KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$66,250

Shares × reported transaction price

Timing vs results

19 days after results of Apr 23, 2026, 72 days before results of Jul 23, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $79.73 on May 12, 2026, 10% above its 52-week low and 9% below its high, little changed over the previous 30 trading days

52-week range $72.65 (Oct 16, 2025) to $87.18 (Mar 2, 2026), 49% of the way up, from 251 adjusted closes. 30 trading days earlier: $79.50 on Mar 30, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Oct 14, 2024 in the U.S. District Court, C.D. California. A filing is an allegation, not a finding.

Dhimant Patel v. Edwards Lifesciences Corporation, docket 8:24-cv-02221, via CourtListener (court records). Nature of suit 850, company named as first defendant

After it was reported

After	Stock	S&P 500	Difference
7 days	+1.9%	−0.1%	+2.1%
30 days	+4.6%	−0.1%	+4.7%
90 days	+15.1%	+3.8%	+11.3%

Past results only. Not a forecast.

Source receipt

Record ID: 0001225208-26-005172
Filed / recorded: May 12, 2026, 8:55 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: Edwards Lifesciences Corp
Issuer CIK: 1099800
Ticker: EW
Reporting person: Bernard J Zovighian
Relationship: Director, Officer
Officer title: CEO
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: May 12, 2026
Transaction code: S
Shares / units: 845
Price per share: $78.40
Acquired / disposed: Disposed (D)
Shares owned after: 47,545.5511
Ownership form: Indirect — By Trust
Amendment: No

Footnotes from the filing

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
This transaction was executed in multiple trades at prices ranging from $78.390 to $78.430. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Around the same time

Officer sold

~$49KReported value · 567.53 sh @ $86.08

4mo ago

Edwards Lifesciences's SVP, Corporate Controller sold $49K of Edwards Lifesciences shares. Nobody planned it ahead of time.

More Official record

Officer sold

~$2MReported value · 23K sh @ $86.42

4mo ago

Edwards Lifesciences's CVP,Strategy/Corp Development sold $2M of Edwards Lifesciences shares. Nobody planned it ahead of time.

More Official record

Officer sold

~$127KReported value · 1,500 sh @ $84.60

5mo ago

Edwards Lifesciences's CVP, TMTT & Surgical sold $127K of Edwards Lifesciences shares. Nobody planned it ahead of time.

More Official record